Related Experiment Videos
Pathological laughter following intravenous sodium valproate
1Department of Medicine (Neurology), College of Medicine, Sultan Qaboos University, Muscat, Oman.
Summary
Pathological laughter, a symptom of various conditions, can be an unexpected side effect of intravenous sodium valproate treatment for epilepsy. This study highlights a potential adverse reaction in patients receiving this medication.
Area of Science:
- Neurology
- Pharmacology
Background:
- Pathological laughter is a complex symptom associated with neurological and psychiatric conditions.
- Differential diagnosis includes epilepsy, toxins, psychotropic drugs, and structural brain disease.
Observation:
- Two epilepsy patients experienced inappropriate, uncontrollable laughter after receiving intravenous sodium valproate.
- This symptom emerged as a direct consequence of the administered treatment.
Findings:
- Intravenous sodium valproate can induce pathological laughter as an adverse effect.
- The study identifies a novel side effect of this specific drug formulation and administration route.
Implications:
- Clinicians should consider pathological laughter as a potential side effect of intravenous sodium valproate.
- This finding may necessitate revised treatment protocols or patient monitoring for epilepsy management.